LawPlayer
My bookmarks
Source

Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (Text with EEA relevance)

Commission Implementing Regulation (EU) 2016/950 of 15 June 2016 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2,4-DB, beta-cyfluthrin, carfentrazone ethyl, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), cyazofamid, deltamethrin, dimethenamid-P, ethofumesate, fenamidone, flufenacet, flurtamone, foramsulfuron, fosthiazate, imazamox, iodosulfuron, iprodione, isoxaflutole, linuron, maleic hydrazide, mesotrione, oxasulfuron, pendimethalin, picoxystrobin, silthiofam and trifloxystrobin (Text with EEA relevance)

Implementing Regulation (EU) 2016/950 Β· Regulation Β· 3 articles

Data as of 2026-07-04 Β· Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. Β· Read the official text β†—

Article 1

Open β†—

Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended in accordance with the Annex to this Regulation.

Article 2

Open β†—

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Supplementary provisions

ANNEXSupplementary provisions

Open β†—

ANNEX Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows: (1) in the sixth column, expiration of approval, of row 29, Ethofumesate, the date is replaced by β€˜31 July 2017’; (2) in the sixth column, expiration of approval, of row 40, Deltamethrin, the date is replaced by β€˜31 October 2017’; (3) in the sixth column, expiration of approval, of row 41, Imazamox, the date is replaced by β€˜31 July 2017’; (4) in the sixth column, expiration of approval, of row 42, Oxasulfuron, the date is replaced by β€˜31 July 2017’; (5) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by β€˜31 July 2017’; (6) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by β€˜31 July 2017’; (7) in the sixth column, expiration of approval, of row 47, 2,4-DB, the date is replaced by β€˜31 October 2017’; (8) in the sixth column, expiration of approval, of row 48, Beta-cyfluthrin, the date is replaced by β€˜31 October 2017’; (9) in the sixth column, expiration of approval, of row 50, Iprodione, the date is replaced by β€˜31 October 2017’; (10) in the sixth column, expiration of approval, of row 51, Linuron, the date is replaced by β€˜31 July 2017’; (11) in the sixth column, expiration of approval, of row 52, Maleic hydrazide, the date is replaced by β€˜31 October 2017’; (12) in the sixth column, expiration of approval, of row 53, Pendimethalin, the date is replaced by β€˜31 July 2017’; (13) in the sixth column, expiration of approval, of row 59, Trifloxystrobin, the date is replaced by β€˜31 July 2017’; (14) in the sixth column, expiration of approval, of row 60, Carfentrazone ethyl, the date is replaced by β€˜31 July 2017’; (15) in the sixth column, expiration of approval, of row 61, Mesotrione, the date is replaced by β€˜31 July 2017’; (16) in the sixth column, expiration of approval, of row 62, Fenamidone, the date is replaced by β€˜31 July 2017’; (17) in the sixth column, expiration of approval, of row 63, Isoxaflutole, the date is replaced by β€˜31 July 2017’; (18) in the sixth column, expiration of approval, of row 64, Flurtamone, the date is replaced by β€˜31 October 2017’; (19) in the sixth column, expiration of approval, of row 65, Flufenacet, the date is replaced by β€˜31 October 2017’; (20) in the sixth column, expiration of approval, of row 66, Iodosulfuron, the date is replaced by β€˜31 October 2017’; (21) in the sixth column, expiration of approval, of row 67, Dimethenamid-P, the date is replaced by β€˜31 October 2017’; (22) in the sixth column, expiration of approval, of row 68, Picoxystrobin, the date is replaced by β€˜31 October 2017’; (23) in the sixth column, expiration of approval, of row 69, Fosthiazate, the date is replaced by β€˜31 October 2017’; (24) in the sixth column, expiration of approval, of row 70, Silthiofam, the date is replaced by β€˜31 October 2017’; (25) in the sixth column, expiration of approval, of row 71, Coniothyrium minitans Strain CON/M/91-08 (DSM 9660), the date is replaced by β€˜31 October 2017’.

Other acts of the same type
Commission Implementing Regulation (EU) 2019/363 of 13 December 2018 laying down implementing technical standards with regard to the format and frequency of reports on the details of securities financing transactions (SFTs) to trade repositories in accordance with Regulation (EU) 2015/2365 of the European Parliament and of the Council and amending Commission Implementing Regulation (EU) No 1247/2012 with regard to the use of reporting codes in the reporting of derivative contracts (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/364 of 13 December 2018 laying down implementing technical standards with regard to the format of applications for registration and extension of registration of trade repositories in accordance with Regulation (EU) 2015/2365 of the European Parliament and of the Council (Text with EEA relevance.)Commission Implementing Regulation (EU) 2019/365 of 13 December 2018 laying down implementing technical standards with regard to the procedures and forms for exchange of information on sanctions, measures and investigations in accordance with Regulation (EU) 2015/2365 of the European Parliament and of the Council (Text with EEA relevance.)Commission Delegated Regulation (EU) 2019/1011 of 13 December 2018 amending Commission Delegated Regulation (EU) 2017/565 as regards certain registration conditions to promote the use of SME growth markets for the purposes of Directive 2014/65/EU of the European Parliament and of the Council (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1967 of 12 December 2018 amending Regulation (EU) No 37/2010 to classify the substance paromomycin as regards its maximum residue limit (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1969 of 12 December 2018 operating deductions from fishing quotas available for certain stocks in 2018 on account of overfishing in the previous yearsRegulation (EU) 2018/2000 of the European Parliament and of the Council of 12 December 2018 amending Regulation (EU) No 516/2014 of the European Parliament and of the Council, as regards the recommitment of the remaining amounts committed to support the implementation of Council Decisions (EU) 2015/1523 and (EU) 2015/1601 or the allocation of those amounts to other actions under the national programmesCommission Delegated Regulation (EU) 2019/320 of 12 December 2018 supplementing of Directive 2014/53/EU of the European Parliament and of the Council with regard to the application of the essential requirements referred to in Article 3(3)(g) of that Directive in order to ensure caller location in emergency communications from mobile devicesCommission Delegated Regulation (EU) 2019/442 of 12 December 2018 amending and correcting Delegated Regulation (EU) 2017/587 to specify the requirement for prices to reflect prevailing market conditions and to update and correct certain provisions (Text with EEA relevance.)Commission Implementing Regulation (EU) 2018/1957 of 11 December 2018 amending Regulation (EC) No 885/2010 as regards the terms of authorisation of the preparation of narasin and nicarbazin as a feed additive for chickens for fattening (holder of authorisation Eli Lilly and Company Ltd) (Text with EEA relevance.)Regulation (EU) 2018/1971 of the European Parliament and of the Council of 11 December 2018 establishing the Body of European Regulators for Electronic Communications (BEREC) and the Agency for Support for BEREC (BEREC Office), amending Regulation (EU) 2015/2120 and repealing Regulation (EC) No 1211/2009 (Text with EEA relevance)Commission Implementing Regulation (EU) 2018/1990 of 11 December 2018 establishing the forms referred to in Council Regulation (EU) 2016/1104 implementing enhanced cooperation in the area of jurisdiction, applicable law and the recognition and enforcement of decisions in matters of the property consequences of registered partnerships

Source: EUR-Lex (Publications Office of the EU), Β© European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next